JSS Sustainable Equity - Future Health Y USD acc

Reference Data

ISIN LU2041627279
Valor Number 49491348
Bloomberg Global ID
Fund Name JSS Sustainable Equity - Future Health Y USD acc
Fund Provider J. Safra Sarasin Investmentfonds AG Basel, Switzerland
Phone: +41 58 317 44 44
Web: www.jsafrasarasin.com
Fund Provider J. Safra Sarasin Investmentfonds AG
Representative in Switzerland J. Safra Sarasin Investmentfonds AG
Basel
Phone: +41 58 317 44 00
Distributor(s) Bank J. Safra Sarasin AG
Basel
Phone: +41 58 317 44 00
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD). The assets of the fund are mainly invested worldwide either directly (min. 67% of the SubFund’s assets) or indirectly in equity securities that offer an exposure to one or multiple emerging and transformational health trends. The Sub-Fund invests in leading companies and niche players whose products and services contribute to the improvement of health outcome and the dampening of rising healthcare costs.
Peculiarities

Fund Prices

Current Price * 117.46 USD 12.06.2025
Previous Price * 116.55 USD 11.06.2025
52 Week High * 128.05 USD 30.08.2024
52 Week Low * 105.13 USD 08.04.2025
NAV * 117.46 USD 12.06.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 135,849,377
Unit/Share Assets *** 5,617,196
Trading Information SIX

Performance

YTD Performance +4.12% 31.12.2024
12.06.2025
YTD Performance (in CHF) -7.06% 31.12.2024
12.06.2025
1 month +3.41% 12.05.2025
12.06.2025
3 months +0.09% 12.03.2025
12.06.2025
6 months +0.80% 12.12.2024
12.06.2025
1 year -3.09% 12.06.2024
12.06.2025
2 years -3.84% 12.06.2023
12.06.2025
3 years +5.94% 13.06.2022
12.06.2025
5 years +7.84% 12.06.2020
12.06.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 9.82%
Danaher Corp 7.04%
Lonza Group Ltd 5.42%
Siemens Healthineers AG Registered Shares 5.23%
Sanofi SA 5.19%
Intuitive Surgical Inc 5.13%
Novo Nordisk AS Class B 4.28%
AbbVie Inc 4.23%
argenx SE 4.16%
Zoetis Inc Class A 3.83%
Last data update 30.04.2025

Cost / Risk

TER 0.95%
TER date 31.10.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.00%
Ongoing Charges *** 0.98%
SRRI ***
SRRI date *** 31.05.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)